CIC

Entertainment Union Coalition On Governor Newsom's Announcement Of His Support For SB 485

Retrieved on: 
Thursday, August 4, 2022 - 1:46pm

LOS ANGELES, Aug. 4, 2022 /PRNewswire/ -- The Entertainment Union Coalition has issued the following statement regarding Governor Newsom's stated support of SB 485 extending the California Film & Television Tax Credit Program to 2030:

Key Points: 
  • LOS ANGELES, Aug. 4, 2022 /PRNewswire/ -- The Entertainment Union Coalition has issued the following statement regarding Governor Newsom's stated support of SB 485 extending the California Film & Television Tax Credit Program to 2030:
    "Today Governor Newsom gave the 163,000 women and men we represent who work in the California film and television industry a lifeline.
  • We thank Governor Newsom for his longstanding support of working families, culminating in his announcement today.
  • We thank the bill's author, Senator Portantino for his steadfast commitment to keeping this industry and those who work in it in California.
  • The Members of the Entertainment Union Coalition (EUC) are: California IATSE Council (CIC); Directors Guild of America, LiUNA!

Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002

Retrieved on: 
Wednesday, August 3, 2022 - 2:16am

The primary objective of the China CHAMP and Mini-CHAMP trials is to evaluate the efficacy and safety of NVK002 for the treatment of myopia progression in children and adolescents.

Key Points: 
  • The primary objective of the China CHAMP and Mini-CHAMP trials is to evaluate the efficacy and safety of NVK002 for the treatment of myopia progression in children and adolescents.
  • These early completions of patient recruitment across both trials, gives the company a strong headstart in moving towards its goal to lead the market in launching a myopia progression treatment drug.
  • Following this, a New Drug Application ("NDA") submission to the US Food and Drug Administration (the "FDA") is expected in 2023.
  • Dr. Li Xiaoyi (Benjamin), Chairman of the Board of Directors, Executive Director and CEO of Zhaoke Ophthalmology, said, "The early completion of the patient recruitment of NVK002's Phase III clinical trials marks another huge and exciting milestone for Zhaoke Ophthalmology.

Academic Director Dustyne Bryant, MBA, CIC, CISR Named as APCIA 2022 Emerging Leader

Retrieved on: 
Friday, July 29, 2022 - 1:31pm

AUSTIN, Texas, July 29, 2022 /PRNewswire/ -- The National Alliance for Insurance Education & Research proudly announces the selection of Dustyne Bryant, MBA, CIC, CISR , as one of the American Property Casualty Insurance Association 2022 Emerging Leaders .

Key Points: 
  • AUSTIN, Texas, July 29, 2022 /PRNewswire/ -- The National Alliance for Insurance Education & Research proudly announces the selection of Dustyne Bryant, MBA, CIC, CISR , as one of the American Property Casualty Insurance Association 2022 Emerging Leaders .
  • Along with Director of High School Programs, Noelle Codispoti, they will participate in this year's Emerging Leaders Conference in Denver, Colorado this August.
  • Mrs. Bryant shared this regarding her Emerging Leader Selection:
    "Along with The National Alliance for Insurance Education & Research, APCIA and AM Best are organizations I've respected my entire career.
  • I am honored to be selected as a Class of 2022 Emerging Leader and to stand alongside other amazing Rising Stars.

MaaT Pharma Reports Cash and Revenues for Second Quarter 2022

Retrieved on: 
Thursday, July 28, 2022 - 5:00pm

MaaT Pharma (EURONEXT: MAAT the Company), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today reported its cash position as of June 30, 2022, and its revenues for the second quarter of 2022.

Key Points: 
  • MaaT Pharma (EURONEXT: MAAT the Company), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today reported its cash position as of June 30, 2022, and its revenues for the second quarter of 2022.
  • The second quarter of 2022 saw further progress in our pipeline and the achievement of a crucial milestone for MaaT Pharma.
  • MaaT Pharma reported revenues4 from its compassionate access program of EUR 0.2 million for the quarter ended June 30, 2022, compared with EUR 0.3 million for the first quarter of 2022.
  • In 2021, revenues were invoiced as of February 2021 whereas in 2022 the Company benefits from a full 6 months of revenues.

Rocket Lab to Supply Solar Power for United States Space Force’s New Missile Warning Satellites

Retrieved on: 
Wednesday, July 27, 2022 - 9:15pm

Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, announced that its high-efficiency, radiation-hardened Coverglass Interconnected solar Cell (CIC) assemblies will power the three Lockheed Martin Next Gen OPIR GEO (NGG) satellites for the United States Space Force (USSF).

Key Points: 
  • Rocket Lab USA, Inc. (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, announced that its high-efficiency, radiation-hardened Coverglass Interconnected solar Cell (CIC) assemblies will power the three Lockheed Martin Next Gen OPIR GEO (NGG) satellites for the United States Space Force (USSF).
  • The NGG program will deliver resilient global missile warning capabilities to counter emerging missile and counter-space threats and is part of the latest evolution of the USSFs missile warning system, following the Space Based Infrared System (SBIRS) program, which was supported by SolAero, a space solar power company acquired by Rocket Lab in January 2022.
  • We are excited to continue our long-term partnership with Lockheed Martin by powering the Next Gen OPIR GEO satellites, said Brad Clevenger, Rocket Labs Vice President & General Manager, Space Systems Power Solutions.
  • These satellites are critical to the mission needs of the United States Space Force and our national security, and we are proud to be supporting their production on an aggressive schedule.

SrinSoft, Cleo Form Partnership to Expand Ecosystem Integration Adoption and Drive Organizational Agility Via Any-to-Any Integration

Retrieved on: 
Tuesday, July 26, 2022 - 2:00pm

SrinSofts global team of more than 500 consultants has strong expertise in IT, Digital & Data Transformation & Engineering Services.

Key Points: 
  • SrinSofts global team of more than 500 consultants has strong expertise in IT, Digital & Data Transformation & Engineering Services.
  • Likewise, Cleo is a well-known leader in cloud-based B2B integration, providing API, EDI, and non-EDI integration solutions to more than 4,100 supply chain-driven organizations who leverage Cleos cloud platform to drive revenue via improved visibility and control made possible through enhanced organizational agility.
  • Cleos objective is helping its customers improve ecosystem relationships, increase revenue, reduce costs, and maintain a competitive edge through modern integration technology solutions.
  • Cleo Integration Cloud (CIC) is a cloud-based integration platform, purpose-built to design, build, operate and optimize critical ecosystem integration processes.

Crazy Internet Coin (CIC) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Friday, July 22, 2022 - 5:02am

Internet City, Dubai--(Newsfile Corp. - July 22, 2022) - LBank Exchange, a global digital asset trading platform, has listed Crazy Internet Coin (CIC) on July 20, 2022.

Key Points: 
  • Internet City, Dubai--(Newsfile Corp. - July 22, 2022) - LBank Exchange, a global digital asset trading platform, has listed Crazy Internet Coin (CIC) on July 20, 2022.
  • For all users of LBank Exchange, the CIC/USDT trading pair is now officially available for trading.
  • Its native coin Crazy Internet Coin (CIC) has been listed on LBank Exchange at 16:00 (UTC+8) on July 20, 2022, to further expand its global reach and help it achieve its vision.
  • Investors who are interested in Crazy Internet Coin investment can easily buy and sell CIC on LBank Exchange now.

Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call

Retrieved on: 
Thursday, July 21, 2022 - 9:01pm

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022.

Key Points: 
  • Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022.
  • The call will be available for replay via telephone starting Thursday, August 4, 2022 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on August 18, 2022.
  • To listen to the replay, dial (800) 770-2030 (U.S. and Canada) or (647) 362-9199 (international) using conference ID number 4671230.
  • Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.

Waterdrop Launches Industry's First Customized Critical Illness Insurance Product with Waiver on Health Declarations

Retrieved on: 
Thursday, July 21, 2022 - 11:00am

Today, we are pleased to jointly launch the 'Waterdrop Blue Ocean' with CIC and Yong An, a series of cost-effective customized critical illness product with a waiver on health declarations, dedicated to customers with pre-existing medical conditions."

Key Points: 
  • Today, we are pleased to jointly launch the 'Waterdrop Blue Ocean' with CIC and Yong An, a series of cost-effective customized critical illness product with a waiver on health declarations, dedicated to customers with pre-existing medical conditions."
  • 'Waterdrop Blue Ocean' has waived the health declaration of customers, allowing them to enjoy a more convenient and intelligent insurance service."
  • In regards to insurance claims, the criteria of the "Waterdrop Blue Ocean" series are in line with those of other critical illness products that require health declarations and the claim process remains as efficient as other critical illness products.
  • Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology.

LBank Weekly Listing Report, 18th July 2022

Retrieved on: 
Tuesday, July 19, 2022 - 7:59am

It will be used for governance on their blockchain and also to cover gas fees between transfers, or provide liquidity to tokens that are built on their chain.

Key Points: 
  • It will be used for governance on their blockchain and also to cover gas fees between transfers, or provide liquidity to tokens that are built on their chain.
  • CIC Chain is fast, cheap, scalable, and upgradeable and is powered by our own unique Proof of Refraction consensus mechanism, which is like Proof of Authority, but much more efficient.
  • Crazy Internet Coin is web3 and web5 ready and was built to become a catalyst of mass adoption for blockchain technology.
  • Summary of Last Week's Listings - July 11th to July 17th, 2022